Obtaining protein from unconventional renewable source raw materials.
Public support
Provider
Ministry of Industry and Trade
Programme
IMPULSE
Call for proposals
IMPULS 1 (SMPO200400003)
Main participants
—
Contest type
VS - Public tender
Contract ID
—
Alternative language
Project name in Czech
Získávání bílkovin z netradičních obnovitelných zdrojů surovin.
Annotation in Czech
Projekt vychází z poznatků AMR AMARANTH, a.s. o složení a možnostech využití amarantové biomasy jako zdroj bílkovin a z dosavadních poznatků o potřebách hledání zdrojů bílkovin. Vysoký obsah bílkovin ve výchozí surovině biomasy amarantu a při její vysoképrodukční schopnosti může být do budoucna i významným zdrojem bílkovin. Vhodná kombinace amarantového bílkovinného koncentrátu s dalšími bílkovinami dává možnost řady uplatnění, např. jako funkční potraviny, tech. produkty, komponenty krmiv atp.
Scientific branches
R&D category
PV - Industrial research
CEP classification - main branch
EI - Biotechnology and bionics
CEP - secondary branch
JJ - Other materials
CEP - another secondary branch
—
OECD FORD - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)
20502 - Paper and wood<br>20503 - Textiles; including synthetic dyes, colours, fibres (nanoscale materials to be 2.10; biomaterials to be 2.9)<br>20801 - Environmental biotechnology<br>20802 - Bioremediation, diagnostic biotechnologies (DNA chips and biosensing devices) in environmental management<br>20803 - Environmental biotechnology related ethics<br>20901 - Industrial biotechnology<br>20902 - Bioprocessing technologies (industrial processes relying on biological agents to drive the process) biocatalysis, fermentation<br>20903 - Bioproducts (products that are manufactured using biological material as feedstock) biomaterials, bioplastics, biofuels, bioderived bulk and fine chemicals, bio-derived novel materials<br>21001 - Nano-materials (production and properties)<br>21002 - Nano-processes (applications on nano-scale); (biomaterials to be 2.9)<br>30401 - Health-related biotechnology<br>30402 - Technologies involving the manipulation of cells, tissues, organs or the whole organism (assisted reproduction)<br>30403 - Technologies involving identifying the functioning of DNA, proteins and enzymes and how they influence the onset of disease and maintenance of well-being (gene-based diagnostics and therapeutic interventions [pharmacogenomics, gene-based therapeutics])<br>30404 - Biomaterials (as related to medical implants, devices, sensors)<br>30405 - Medical biotechnology related ethics<br>40401 - Agricultural biotechnology and food biotechnology<br>40402 - GM technology (crops and livestock), livestock cloning, marker assisted selection, diagnostics (DNA chips and biosensing devices for the early/accurate detection of diseases) biomass feedstock production technologies, biopharming<br>40403 - Agricultural biotechnology related ethics
Completed project evaluation
Provider evaluation
V - Vynikající výsledky projektu (s mezinárodním významem atd.)
Project results evaluation
Acceptable
Solution timeline
Realization period - beginning
Jan 1, 2004
Realization period - end
Jan 1, 2006
Project status
U - Finished project
Latest support payment
—
Data delivery to CEP
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data delivery code
CEP07-MPO-FI-U/01:1
Data delivery date
Jun 21, 2007
Finance
Total approved costs
21,278 thou. CZK
Public financial support
8,700 thou. CZK
Other public sources
0 thou. CZK
Non public and foreign sources
12,580 thou. CZK